Table 1 Patient characteristics between the success group and recurrence group
Success group n = 83 | Recurrence group N = 18 | P value | |
|---|---|---|---|
Age, years | 61.4 ± 8.5 | 63.2 ± 8.5 | 0.40 |
Male (%) | 52 (62.7) | 7 (38.9) | 0.06 |
PAF Duration, years | 2.9 ± 2.5 | 4.7 ± 4.7 | 0.13 |
BMI (kg/m2) | 25.1 ± 2.6 | 24.8 ± 3.0 | 0.70 |
CHA2DS2-VASc score | 1.2 ± 0.9 | 1.8 ± 1.3 | 0.07 |
LVEF (%) | 58.0 ± 2.5 | 57.8 ± 2.0 | 0.76 |
Left atrial diameter, mm | 38.0 ± 4.7 | 38.9 ± 4.4 | 0.45 |
Hypertension, n (%) | 18 (21.7%) | 4 (22.2%) | 0.96 |
Coronary disease, n (%) | 6 (7.2%) | 3 (16.7%) | 0.414 |
Diabetes mellitus, n (%) | 6 (7.2%) | 3 (16.7%) | 0.20 |
AI | 421.4 ± 7.6 | 417.6 ± 6.7 | 0.06 |
Baseline impedance (Ω) | 122.9 ± 9.4 | 130.6 ± 8.9 | < 0.01 |
Impedance drop (Ω) | 10.8 ± 1.4 | 10.5 ± 1.3 | 0.41 |
Ratio of impedance drop (%) | 8.8 ± 1.4 | 8.1 ± 1.2 | 0.03 |
First-pass PVI, n (%) | 151 (91.0) | 28 (77.8) | 0.03 |
Number of ablation points | 74.1 ± 7.7 | 76.4 ± 6.7 | 0.24 |